ABDELRAHMAN, GAMALELDEIN FATHY ABDELLATEF

ABDELRAHMAN, GAMALELDEIN FATHY ABDELLATEF  

Mostra records
Risultati 1 - 4 di 4 (tempo di esecuzione: 0.001 secondi).
Titolo Data di pubblicazione Autore(i) File
Curcumin-loaded solid lipid nanoparticles bypass p-glycoprotein mediated doxorubicin resistance in triple negative breast cancer cells 2020 Abd-Ellatef G.-E.F.; Gazzano E.; Chirio D.; Hamed A.R.; Belisario D.C.; Zuddas C.; Peira E.; Rolando B.; Kopecka J.; Marie M.A.S.; Sapino S.; Fahmy S.R.; Gallarate M.; Abdel-Hamid A.-H.Z.; Riganti C.
Different Strategies to Increase Doxorubicin Efficacy in Drug Resistant Cancer Cells Based on Physical, Natural and Pharmacological Approaches 2020 -
Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer 2018 Salaroglio, Iris C; Gazzano, Elena; Abdullrahman, Ahmad; Mungo, Eleonora; Castella, Barbara; Abd-Elrahman, Gamal Eldein Fathy Abd-Ellatef; Massaia, Massimo; Donadelli, Massimo; Rubinstein, Menachem; Riganti, Chiara; Kopecka, Joanna
Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance 2017 Chegaev, Konstantin; Fraix, Aurore; Gazzano, Elena; Abd Ellatef, Gamal Eldein F.; Blangetti, Marco; Rolando, Barbara; Conoci, Sabrina; Riganti, Chiara; Fruttero, Roberta; Gasco, Alberto; Sortino, Salvatore